PPIST15933
Protein Information
| Protein_Chain | A;B |
|---|---|
| Protein_Sequence | GSHMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY |
Peptide Information
| Peptide_Chain | C;D |
|---|---|
| Peptide_Sequence | HASTNMGLEAIIRKALMGKYDQW |
| Peptide_Length | 23 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 8B90 |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 2.10 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists. |
|---|---|
| Release_Year | 2022 |
| PMID | 36542958 |
| DOI | 10.1016/j.bmc.2022.117130 |